Table 2 Clinicopathologic and histologic characteristics and the expression of VISTA and PD-L1 by immunohistochemistry in MPM TMA cohort

From: V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma

 

Overall

n = 319

Epithelioid

n = 254

Biphasic

n = 41

Sarcomatoid

n = 24

p-value*

VISTA raw score, median (range)

50 (0 to 100)

50 (0 to 100)

20 (0 to 95)

0 (0 to 50)

<0.001

PD-L1 raw score, median (range)

0 (0 to 95)

0 (0 to 95)

0 (0 to 95)

20 (0 to 95)

<0.001

Age, median (range)

64 (29 to 85)

63 (29 to 85)

66 (41 to 79)

66 (46 to 78)

0.016

Female, n (%)

82 (25.7)

72 (28.3)

5 (12.2)

5 (20.8)

0.073

Stage, n (%)

     

  1

10

10

0

0

0.023

  2

75

67

4

4

  3

187

147

27

13

  4

47

30

10

7

  1. *p-values compare rows among the three histology groups
  2. MPM malignant pleural mesothelioma, n number, PD-L1 programmed cell death-ligand 1, TMA tissue microarray, VISTA V-domain Ig suppressor of T-cell activation